ACEM Fellowship
Paediatric Nephrotic Syndrome

Paediatric Nephrotic Syndrome

Definition

  • Heavy proteinuria (>50mg/kg per 24 hours), hypoalbuminaemia (<30g/L), oedema and hyperlipidaemia (triglycerides and cholesterol)
    • Do not need all components for diagnosis
  • Plasma proteins up to MW of albumin are lost
    • In severe disease, IgG loss approaches that of albumin
    • Protein selectivity is seen in minimal change disease and increases the likelihood of a steroid responsive illness

Primary (idiopathic) nephrotic syndrome

  • 90% of cases
  • Disease limited to the kidney
  • Steroid-sensitive: Responds fully within 4-6 weeks of therapy
  • Steroid-dependent: 2 consecutive relapses during steroid therapy or within 14 days of cessation
  • Steroid-resistant: Failure to achieve response after 4 weeks of steroids
  • DDx
    • Minimal change disease (85%)
    • Mesangial proliferative GN (5%)
    • Focal segmental glomerusclerosis (10%)

Secondary nephrotic syndrome

  • Lupus
  • Membranoproliferative GN
  • Membranous nephropathy
  • Congenital nephrotic syndrome
  • Hereditary Nephritis
  • Henoch-Schonlein purpura
  • Drugs
    • Phenytoin
    • NSAID
    • Captopril

Features that suggest secondary NS

  • Age <1 or >12 with first episode
  • Systemic symptoms e.g. fever, rash, arthralgia (SLE)
  • Persistent hypertension (can be mild in days 1-2)

Hypercoagulability

  • Results from renal protein wasting
  • Increased blood viscosity
  • Blood flow reduced
  • Fibrinogen levels raised
  • Antithrombin III lost in urine
  • Presentations
    • DVT
    • Renal vein thrombosis – Macroscopic haematuria, palpable kidney, loin tenderness, raised creatinine, HTN
    • Cerebral vein thrombosis – Headache, vomiting, impaired consciousness or focal neurology

Hyperlipidaemia

  • Possibly due to reduced plasma oncotic pressure with subsequent stimulation of lipoprotein synthesis

Investigations

  • Hypoalbuminaemia (<30) occurs in all children with nephrotic syndrome
  • Spot urine protein:creatinine ratio >300mg/nmol
  • Microscopic haematuria in 15%
  • Urinalysis proteinuria 3+ or 4+
  • Haematocrit often elevated
  • Plasma urea and creatinine elevated in 25% (if not mild, consider nephritic syndrome)
  • Serum complement levels are normal in MCNS, FSGS and mesangioproliferative GN
  • Hypertension (may be mild in first 1-2 days)
  • C3/4 (low in SLE and MPGN) and ANA (SLE)

Steroid response

  • Steroid-responsive: If urine becomes free of protein within 4-8 weeks of daily prednisolone
  • Steroid-resistant: Proteinuria >2+ despite 4-8 weeks of therapy. Renal biopsy indicated
  • Renal biopsy also indicated if other signs suggest secondary nephrotic syndrome

Ddx for oedema

  • Congestive heart failure
  • Cirrhosis
  • Starvation
  • Protein-losing enteropathy
  • CF
  • Hypothyroidism
  • Vasculitis
  • Steroid therapy

Treatment

  • Treat hypotension/shock as normal
  • Albumin infusion of 20% can be considered for volume replacement if severely volume deplete or severely oedematous but is only a temporising measure and does risk acute pulmonary oedema
    • Should be given with frusemide
  • If symptomatic from oedema, trial of diuretics can be considered (if not volume deplete)
  • Low salt diet
  • Strict fluid balance
  • Therapeutic paracentesis can be considered for acute respiratory distress from increased abdominal pressure
  • Prednisolone 1mg/kg BD sees proteinuria resolve in 90% within 4-6 weeks
  • Always consider peritonitis in the child with abdominal ascites
  • Pen V antibiotic prophylaxis until oedema subsides
  • Ranitidine as chemoprophylaxis against steroid-induced gastritis
  • Outpatient management if looks well, oedema is not massive and no complications apparent if close follow-up possible
  • Admission
    • Recurrent, severe dehydration, unexplained fever, renal insufficiency, refractory oedema or suspected peritonitis
    • Age <12 months or >12yo
    • Persistent hypertension or microscopic haematuria
    • C3 or C4 depletion
    • Unclear if nephritic or nephrotic

Prognosis

  • Steroid-responsive: 1-2% mortality long-term
  • Most deaths due to peritonitis or sepsis (pneumonia) and thrombus
  • 80% of children with minimal change disease will suffer a relapse and 50% will have frequent relapses
  • Relapses may continue through to adulthood but are usually less severe and respond well to steroids
  • Recovery considered permanent if remains asymptomatic and no requirement for medication for 2 years

Complications

  • Hypogammaglobulinaemia
  • Spontaneous bacterial peritonitis
  • Thromboembolism
  • Symptomatic hypovolaemia
  • Respiratory compromise
  • Hypertensive encephalopathy (on steroid therapy)
  • Benign intracranial hypertension (may be precipitated by abrupt stop in steroid dose)
  • Growth impairment (steroid therapy)

Last Updated on November 10, 2021 by Andrew Crofton